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Effects of hypoxia on renal hormonal balance in 
normal subjects and in patients with COPD 
K. M. SKWARSKI”, D. MORRISON”, A. BARRATT”, M. LEE+ AND W. MACNEE” 
“Respivatauy Medicine and ‘Clinical Pharmacology, Department of Medicine, University of 
Edinbwgh, Scotland, U.K. 
There is a complex interaction between pulmonary haemodynamics, hormonal, and salt and water balance in 
patients with chronic obstructive pulmonary disease (COPD) and in normal subjects exposed to hypoxia or high 
altitude. This study aims to investigate the effects of hypoxia on renal hormonal balance in normal subjects and 
patients with COPD, particularly the role of urinary dopamine and atria1 natriuretic peptide (ANP). 
Urinary dopamine output, ANP, and plasma renin activity (PRA) were measured in 12 normal subjects exposed 
to hypoxia (12% 0,) and hyperoxia (40% 0,) for 1 h and in 15 patients with exacerbations of COPD while breathing 
air or Oz. These measurements were repeated in six of the patients with exacerbations of COPD when they were 
clinically stable. 
Hypoxia caused an increase in ANP levels (49 * 6-62 + 6 pg ml - ‘, BO.05) and a fall in urinary dopamine output 
(277 5 399205 k 33 ng h - ‘, P<O.O02) in normal subjects. Hyperoxia was associated with a return of plasma ANP to 
the baseline values. In patients with exacerbations of COPD plasma ANP levels were higher (181 & 36 pg ml - ‘) 
than in normal subjects (49.5 f 6.5 pg ml- ‘: P<O.OOl). Urinary dopamine output breathing air (175 f 34 ng h - ‘) 
was similar to the levels when normal subjects were made hypoxaemic and PRA was elevated in comparison to 
normal values. There was no change in their levels following the acute administration of oxygen in patients 
presenting with exacerbations of COPD, but oxygen improved urinary sodium excretion (P<O.O5). In six patients 
re-studied when clinically stable there was a fall in urinary dopamine output, plasma ANP and PRA when breathing 
air in comparison to the acute stage of the disease (P<O.O5). 
These data suggest presence of renal hormonal imbalance including endogenous urinary dopamine output during 
hypoxic exacerbation of COPD and in normal subjects exposed to hypoxia. 
RESPIR. MED. (1998) 92, 1331-1336 
Introduction 
Recurrent exacerbations of chronic obstructive pulmonary 
disease (COPD), lead to development of car pulmonale. 
However, the exact pathogenesis of this syndrome remains 
unclear (14). The view that the oedema in car pulmonale is 
due to right heart failure is the subject of much debate 
(1,3,5,6). There is evidence that complex interactions occur 
between pulmonary haemodynamics and hormonal and salt 
and water balance in patients with hypoxic COPD (4,7-9) 
and in normal subjects exposed to hypoxia or living at high 
altitude (10-13). High plasma renin activity (PRA) and 
aldosterone levels are present in patients with respiratory 
failure secondary to COPD (8,14,15). Pulmonary hyper- 
tension which develops as a result of hypoxaemia leads to 
enlargement and dilatation of the right ventricle and 
Received 4 March 1997 and accepted in revised form 24 August 
1998. 
Correspondence should be addressed to: W. MacNee, Unit of 
Respiratory Medicine, Department of Medicine, Royal Infirmary, 
Lauriston Place, Edinburgh EH3 9YW, U.K. 
0954-6111/98/121331+06 $12.00/O 
atrium. Atria1 and ventricular stretch appears to be the 
major stimulus to the secretion of atria1 natriuretic peptide 
(ANP) (4,7:14) which could potentially counteract the 
activation of the renin-angiotensin-aldosterone system 
(RAA). However, there is no general agreement on how the 
renal and endocrine systems are affected by hypoxaemia. 
In recent years it has become apparent that dopamine has 
an important regulatory role in renal function (16-19). The 
main source of renal dopamine appears to be circulating 
L-dopa (16,18,20). Dopamine is formed in the proximal 
convoluted tubule under the action of L-dopa decarboxy- 
lase (L-amino acid decarboxylase LAAD). Dopamine pro- 
duced in this way is then free to act on renal dopamine 
receptors leading to vasodilatation and natriuresis (16-18, 
20,21). Whether dopamine has a role in the pathogenesis of 
the oedema in hypoxic COPD has not been established. 
In this study our aim was to examine plasma renin, renal 
dopamine output and plasma ANP levels during acute 
normocapnic hypoxia and hyperoxia in normal subjects. 
We also wished to examine the same factors in patients with 
acute and stable COPD, before and after the administration 
of oxygen. 
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Methods 
The study had ethical approval by the regional ethics 
committee. It was conducted in the Department of 
Medicine, Unit of Respiratory Medicine and in the Rayne 
Laboratory, University of Edinburgh. 
TABLE 1. Patient characteristics 
STUDY POPULATIONS 
Normal subjects 
Twelve normal subjects (all male), mean age 27 years (range 
23-39 years) were studied. None had respiratory, cardiac, 
hepatic or renal disease, as assessed by clinical examination 
and standard laboratory tests. None were receiving any 
medication. Blood samples were obtained from a peripheral 
venous catheter. Arterial oxygen saturation (SaO,) was 
monitored continuously using a pulse oximeter (Hewlett- 
Packard). Breath-by-breath end-tidal CO, and 0, were 
measured using a mass spectrometer. Hypoxia was induced 
by breathing a gas mixture containing 12% 0,. Isocapnic 
hypoxia was maintained by the addition of CO, using a 
rotameter system which maintained end-tidal PCO, con- 
stant. SaO, was maintained at 80% during hypoxia and at 
98100% during hyperoxia while breathing 40% 0,. 
Each study was performed in the morning. The subjects 
had a light breakfast, 2 h prior to the study. They were 
studied semi-recumbent. An intravenous cannula was 
inserted into an antecubital vein. The subjects breathed 
room-air through a mouthpiece for 2 h. Saline 0.9% was 
infused at a rate of 150 ml h - r throughout the study to 
maintain adequate urinary output. SaO, was measured 
continuously using a pulse oximeter and heart rate and 
rhythm using a cardiac monitor. 
After the first hour of baseline measurements the subjects 
emptied their bladder and the urine sample was discarded. 
At the end of the second hour of baseline measurements 
plasma ANP and renin activity, electrolytes, urea and 
creatinine were measured. Urine was collected to measure 
dopamine output and urinary sodium excretion. An identi- 
cal set of measurements was obtained at the end of each 
subsequent l-h period, when the subjects had breathed 12% 
and 40% O,, respectively. Plasma renin activity was 
measured in only six of the subjects. 
Patients with COPD 
We studied 15 patients presenting with an exacerbation of 
COPD (Table 1). These patients presented with worsening 
blood gas values and increasing dyspnoea, but without 
acute acidosis. Patients were studied within an hour of 
admission, when breathing room-air. Repeated measure- 
ments were made breathing 0, (2 1 min - ’ via nasal prongs) 
for 1 h. Measurements were repeated again breathing air 
and O,, when the patients condition was stable, at least 
6 weeks after the exacerbation (n=6) (Table 1). Drug 
therapy in these patients during their acute episode 
included, oxygen 2 1 min - ’ by nasal prongs, nebulized 
bronchodilators, antibiotics as appropriate and diuretics 
(4OG80 mg frusemide) in those with oedema (n=7). 
Acute exacerbations of: 
COPD Stable COPD 
Age (years) 
J-V, (1) 
FEV (% pred) 
PaO, (air) (kPa) 
Pa% (0,) NW 
PaCO, (air) (kPa) 
PaCO, (0,) (kPa) 
H’ (air) (nmol l- ‘) 
H+ (0,) (nmol l- ‘) 
n=15 
68 f 5 
0.6 zt 0.2 
21 Lt 34 
6.9 rk 1.1 
10.1 + 2.1 
6.2 ?e 1.1 
6.6 + 1.3 
36.9 + 3.9 
38.8 i 4.2 
n=6 
66&t 
7.9 * 1.0” 
10.9 i 1.9 
5.8 zt 0.6 
co.05 
35.8 EIZ 2.1 
31 f 3.5 
"P<O.O5. 
HORMONAL ASSAYS 
Plasma ANP 
Ten ml of venous blood were withdrawn into chilled EDTA 
tubes. Plasma was rapidly separated by centrifugation, 
stored at - 70°C and assessed in batches within 2 months. 
ANP was measured in these samples by a specific radio- 
immunoassay using commercial kit. ANP antibody was 
raised in rabbit by conjugation of synthetic ANP l-28 
with bovine thyroglobulin, using carbodimide as the 
coupling agent. ANP was extracted from plasma using 
Sep-Pak C-1P cartridges (Waters Ass, U.K.) and diluted 
with a mixture of ethanol, water and acetic acid. The lower 
limit of detection for the assay was 10 pg ml - i. The level of 
ANP was measured using 13’1- ANP as the radioactive 
tracer (Amersham International, U.K.). The range of 
plasma ANP in our laboratory in normal subjects is 
lo-55 pg ml- ‘. 
Plasma venin activity and aldosterone levels 
Plasma renin activity was determined indirectly by the 
generation of angiotensin I and then by radioimmuno- 
assay of this peptide. Plasma aldosterone was determined 
by a double antibody technique (Coat a Count U.K., 
commercial kit). 
Urinary dopamine [in-house assay} 
Urine samples were collected into 5 M HCl as a preserva- 
tive. Dopamine was measured after extraction .from urine 
by a modification of the method of Anton and:Sayre (20). 
In brief, dopamine was measured by high-performance 
liquid chromatography (HPLC) using a Millipore 4u 
‘Novapack’ column under radial compression. Eluates 
from the column were recorded using a Shimadzu comput- 
ing integrator. Epinephrine was added to all samples in 
standard concentrations as an internal standard. The stan- 
dard response was calibrated by division of the area of the 
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internal standard into five known concentrations and 
unknowns were derived from this. Intra- and inter-assay 
coefficients of variation were 1.0% and 2.2%, respectively. 
STATISTICAL ANALYSIS 
Non-parametric tests were used in the statistical analysis 
due to not normal data distribution. Comparisons between 
mean values were made using the Wilcoxon signed-rank test 
for the same group and unpaired standard t-test for com- 
parison between groups. A P-value less than 0.05 was 
considered statistically significant. 
Correlations were obtained using linear regression 
analysis. 
Results 
NORMAL SUBJECTS 
Response to hypoxia and hyperoxia 
Following hypoxia for 1 h, when the subjects breathed 12% 
O,, their SaO, dropped from 98% to 80%. Mean plasma 
ANP concentration, measured at the end of this period 
increased from 49 f 6 to 62 I-t 6 pg ml- ’ (mean & SEM); 
P~0.05. Hypoxia also produced a fall in urinary dopamine 
output from 277 i. 39 to 175 f 34 ng h- ‘, P<O401. Urinary 
sodium fell from 124 f 10 to 63 & 12 mmol h- ‘, P~O.001; 
in addition we observed a trend towards a decrease in renin 
activity which was not statistically significant. 
After hyperoxia the mean SaO, rose to 99% and was 
associated with a return to plasma ANP to control values 
breathing air (44 i 5 pg ml - *). Following hyperoxia we did 
not observe a significant difference in urinary dopamine 
output in comparison to the period of hypoxia, but the 
level was still significantly lower than during the control 
period, breathing air (224 * 3X ng h ~ I). However, there 
was a further fall in plasma renin activity (0.59 + 
0~09ngmll’h~‘, P<O.Ol) during hypoxia. Urinary 
sodium was higher during hyperoxia in comparison to the 
hypoxic period (101 f 28 mmol hh’: P<O.Ol) and was 
similar to control values when breathing air. Combined 
results of the response to hypoxia and hyperoxia in normal 
subjects are shown in Table 2. 
Patients with CQPD 
Patients studied during acute exacerbations of COPD had 
higher ANP levels (18 1 + 36 pg ml - ‘) than normal subjects 
(49.5 & 6.3 pg ml- ‘, P<O.OOl). ANP levels in plasma did 
not change when breathing 0, (2 1 min ~ ’ via nasal prongs). 
Urinary dopamine output breathing air (205 & 33 ng h - ‘) 
was similar to the levels when normal subjects breathed 
the hypoxic gas mixture (175 & 34 ng h ~ ‘). There was a 
trend for urinary dopamine output to decrease after 0, 
administration, although this change was not statistically 
significant. Compared with normal values PRA 
(12 + 3 ng ml ~ ’ h - ‘) levels were elevated in patients with 
acute exacerbations of COPD while breathing room air and 
did not change while breathing 0,. However, admin- 
istration of 0, increased urinary sodium significantly (from 
3 1 + 11 to 39 i 9 mmol h- ‘, P<O.O5). Plasma ANP breath- 
ing either air and 0, correlated significantly with the PRA 
(~10.82) (~~=0.68, P<O.OOl). Combined results of the effect 
of hypoxia and supplementary 0, administration during 
acute exacerbation of COPD are shown in Table 3. 
In six patients re-studied 6 weeks after their exacerbation 
(when clinically stable) there was significant improvement 
in their partial arterial 0, pressure while breathing room- 
air (from 6.4 4 1.5 to 7.9 i 1.2 kPa, P<.O.O5). There was 
also a significant fall in urinary dopamine output on 
air from the exacerbation (178 + 41 ng 1-l) to the time 
of clinical stability (76 + 18 ng l- ‘, PcO.05). We also 
observed a lower plasma ANP level breathing both air 
and oxygen at clinical stability compared with correspond- 
ing levels during the exacerbation (P<O.O05). A similar 
trend was also shown for PRA. Combined results of this 
comparison are shown in Table 4. 
iscussio 
The development of chronic hypoxia (PaO,<S.O kPa) in 
patients with COPD leads to pulmonary vasoconstriction 
and eventually irreversible changes in the pulmonary vas- 
culature, resulting in turn to chronic pulmonary hyperten- 
sion and increased right ventricular afterload (22,23). 
During exacerbations such patients can develop even higher 
levels of pulmonary arterial pressure, raised jugular venous 
pressure and oedema (24,25). 
Hypoxia has been shown to affect renal function in both 
normal subjects and in hypoxaemic patients with COPD. 
Reduced renal blood flow during hypoxia is thought to 
induce activation of the renin-angiotensin-aldosterone sys- 
tem (11,13,26). In addition plasma ANP is higher in such 
patients (7,8,14) and also increases in normal volunteers 
exposed to hypoxia (27). Dopamine also has an important 
modulating effect on renal function (10?!7-19,28). How- 
ever, the effects of acute or chronic hypoxaemia on urinary 
dopamine output in patients with hypoxic COPD and in 
normal subjects has not been studied. Endogenous renal 
dopamine produces a natriuresis (16,18) by three mech- 
anisms: (1) by an action on the renal tubules via dopamine 
receptors, (2) by vasodilatation of the renal vasculature, 
thus increasing GFR and possibly also (3) by inhibiting 
renin release. 
Our hypothesis was that hypoxia would result in a fall in 
the renal dopamine output followed by a decreased sodium 
excretion in the urine. Moreover, activation of the renin 
angiotensin-aldosterone system by hypoxia would also 
result in vasoconstriction and fluid overload. In our study 
hypoxia did result in a fall in urinary dopamine output and 
a decrease in urinary sodium in normal subjects. In addition 
we observed a significant fall in PRA during hypoxia, 
although plasma ANP rose. It has been shown previously in 
experimental animals that the release of ANP is enhanced 
during acute or chronic hypoxia (29). In normal human 
volunteers, as well as in patients with hypoxic COPD, 
hypoxia induces a decrease in plasma aldosterone despite a 
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rise or no change in PRA. Similar findings were observed in 
patients with COPD receiving an infusion of ANP which 
reduced plasma aldosterone levels without influencing PRA. 
The observed increase in plasma ANP during hypoxia in 
our normal volunteers could be in response to the reduced 
sodium excretion by the hypoxic kidneys and the reduction 
in endogenous dopamine which would lead to activation 
of the renin-angiotensin-aldosterone system (13,30,31). 
Although these subjects were hypoxic, the partial pressures 
of 0, in the kidney were not known. By contrast, compared 
with hypoxia, hyperoxia reduced plasma ANP and returned 
urinary sodium levels to control values and decreased PRA. 
However, these changes were not accompanied by signifi- 
cant changes in urinary dopamine output. A further mech- 
anism for the increase in ANP could be as a result of 
hypoxic pulmonary vasoconstriction, causing the release of 
ANP due to right atria1 stretch (4,7). 
These data, from studies in which hypoxia was induced 
acutely in normal subjects, were compared and contrasted 
with data obtained in patients presenting with acute exacer- 
bations of COPD. Plasma ANP and PRA levels were higher 
in patients with an acute exacerbation of COPD than in 
normal subjects and reverted to normal levels when 
repeated at a time when the patients were clinically stable. 
Urinary dopamine output during the acute exacerbation of 
COPD was lower than in normal subjects breathing air but 
was similar to the values obtained when normal subjects 
were made acutely hypoxaemic. 
Chronic hypoxaemia in patients with COPD is associated 
with a fluid and salt retaining state in that there is activation 
of the renin-angiotensin system, a low urinary sodium and 
dopamine output but balanced against high plasma ANP. 
The effects of 0, on dopamine output could be mediated by 
a direct effect on the proximal tubules or on the synthesis or 
degradation of dopamine (32). Dopamine has been shown 
to act in such a way in numerous situations such as in pre- 
eclamptic toxaemia (33) and in primary aldosteronism (18). 
However, in some cases the natriuretic effect of a raised 
plasma ANP and urinary dopamine are overwhelmed by 
the salt-retaining effect of the activated renin-angiotensin 
system and thus these compensatory mechanisms 
(dopamine and ANP) fail, and oedema develops. 
This study of the effects of acute hypoxia supports the 
hypothesis that changes in plasma ANP level: renal hormo- 
nal system and urinary dopamine output are observed in 
acute exacerbation of COPD and may be important in the 
pathogenesis of the clinical syndrome of car pulmonale in 
patients with hypoxic COPD. 
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